Brief intervention for drug-using rural women at high-risk for HIV/HCV

对艾滋病毒/丙型肝炎高危农村吸毒妇女的简短干预

基本信息

  • 批准号:
    8507200
  • 负责人:
  • 金额:
    $ 53.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-15 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high-risk for HIV and HCV. This project has potential to make a significant contribution to science by advancing knowledge about the health disparities, high-risk behaviors (injection drug use, sex risk), and service utilization of this high-risk, vulnerable, an understudied group of women during a time of emerging and significant public health risk in an Appalachian rural setting. This project will incorporate standardized screening (NIDA-modified ASSIST) to identify high-risk rural women drug users from jails, including injectors. Consenting women (N=350) will be asked to participate in a baseline interview, and will then be randomly assigned to one of two study groups: (1) HIV Education (HIV- Ed n=175) which includes the NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources; or (2) Motivational Interviewing- based HIV Risk Reduction (MI-HIV n=175) which, in addition to what is received in the HIV-Ed group, also includes an evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. Specific aims include: (1) to compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV; and (2) to examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug- using rural women at high risk for HIV and HCV. This project is innovative because it 1) targets a high-risk and understudied group of women, 2) uses brief intervention to not only reduce risk behavior but also to enhance motivation for using community health and behavioral health resources, and 3) utilizes a real-world setting to identify high-risk women drug users. The long-term goal of this study is to increase access to health and behavioral health services in order to improve the quality of health of high-risk rural women.
描述(申请人提供):这项研究的总体目标是减少危险行为,提高弱势、吸毒、艾滋病毒和丙型肝炎高危农村妇女的健康和行为卫生服务利用率。该项目有可能对科学做出重大贡献,通过促进对这一高危、脆弱、未得到充分研究的妇女群体在阿巴拉契亚农村地区新出现的重大公共卫生风险期间的健康差距、高风险行为(注射毒品、性风险)和服务利用的了解。该项目将纳入标准化筛查(NIDA修改的ASSIST),以识别监狱中的高危农村妇女吸毒者,包括注射器。同意的妇女(N=350)将被要求参加基线访谈,然后被随机分配到两个研究组之一:(1)艾滋病毒教育(HIV-ED n=175),其中包括NIDA标准的检测前和检测后咨询、艾滋病毒和丙型肝炎快速检测,以及关于现有社区药物滥用和艾滋病毒/丙型肝炎资源的信息包;或(2)以动机访谈为基础的减少艾滋病毒风险(MI-HIV n=175),除了艾滋病毒-ED组接受的干预外,还包括针对高危妇女的循证短暂干预,重点是增强减少危险行为和在社区使用健康和行为健康服务的动机的个体化计划。具体目标包括:(1)比较循证艾滋病毒降低风险干预(MI-HIV)和艾滋病毒教育(NIDA标准)在减少艾滋病毒和丙型肝炎高危弱势农村妇女中的性危险行为、注射做法和药物使用方面的有效性;以及(2)考察MI-HIV干预参与度作为社区卫生和行为卫生服务利用(包括药物治疗和精神健康)的预测因子在弱势、吸毒高危农村妇女艾滋病毒和丙型肝炎高危人群中的后续预测。该项目具有创新性,因为它1)针对高危和研究不足的女性群体,2)使用简单的干预措施,不仅减少危险行为,而且增强使用社区健康和行为健康资源的动机,3)利用现实世界的环境来识别高危女性吸毒者。这项研究的长期目标是增加获得健康和行为健康服务的机会,以提高农村高危妇女的健康质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michele Staton其他文献

Michele Staton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michele Staton', 18)}}的其他基金

Kentucky Women's Justice Community Opioid Innovation Network (WJCOIN)
肯塔基州妇女司法社区阿片类药物创新网络 (WJCOIN)
  • 批准号:
    9978015
  • 财政年份:
    2019
  • 资助金额:
    $ 53.86万
  • 项目类别:
Kentucky Women's Justice Community Opioid Innovation Network (WJCOIN)
肯塔基州妇女司法社区阿片类药物创新网络 (WJCOIN)
  • 批准号:
    10386802
  • 财政年份:
    2019
  • 资助金额:
    $ 53.86万
  • 项目类别:
Kentucky Women's Justice Community Opioid Innovation Network (WJCOIN)
肯塔基州妇女司法社区阿片类药物创新网络 (WJCOIN)
  • 批准号:
    10616702
  • 财政年份:
    2019
  • 资助金额:
    $ 53.86万
  • 项目类别:
Social media HIV prevention intervention for rural women drug users
社交媒体对农村女性吸毒者的艾滋病毒预防干预
  • 批准号:
    9560007
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:
Brief intervention for drug-using rural women at high-risk for HIV/HCV
对艾滋病毒/丙型肝炎高危农村吸毒妇女的简短干预
  • 批准号:
    8667415
  • 财政年份:
    2012
  • 资助金额:
    $ 53.86万
  • 项目类别:
Brief intervention for drug-using rural women at high-risk for HIV/HCV
对艾滋病毒/丙型肝炎高危农村吸毒妇女的简短干预
  • 批准号:
    8409992
  • 财政年份:
    2012
  • 资助金额:
    $ 53.86万
  • 项目类别:
Brief intervention for drug-using rural women at high-risk for HIV/HCV
对艾滋病毒/丙型肝炎高危农村吸毒妇女的简短干预
  • 批准号:
    9045757
  • 财政年份:
    2012
  • 资助金额:
    $ 53.86万
  • 项目类别:
Re-entry Alcohol Services for Rural Offenders
为农村罪犯重新入境提供酒精服务
  • 批准号:
    8199742
  • 财政年份:
    2009
  • 资助金额:
    $ 53.86万
  • 项目类别:
Re-entry Alcohol Services for Rural Offenders
为农村罪犯重新入境提供酒精服务
  • 批准号:
    7904247
  • 财政年份:
    2009
  • 资助金额:
    $ 53.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了